Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 107 articles:
HTML format
Text format



Single Articles


    May 2017
  1. LINCOFF AM, Nicholls SJ, Riesmeyer JS, Barter PJ, et al
    Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    N Engl J Med. 2017;376:1933-1942.
    PubMed     Text format     Abstract available


  2. BHATT DL
    Assessment of Stable Coronary Lesions.
    N Engl J Med. 2017;376:1879-1881.
    PubMed     Text format    


  3. WANG DSH, Mazer CD, Orser BA
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891-2.
    PubMed     Text format    


  4. JIMENEZ-RIVERA JJ, Iribarren-Sarrias JL, Martinez-Sanz R
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891.
    PubMed     Text format    


  5. MYLES PS, Smith JA, Painter T
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1893.
    PubMed     Text format    


  6. MILOJEVIC M, Kappetein AP, Head SJ
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892.
    PubMed     Text format    


  7. DAWES TJ, Price S
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892-3.
    PubMed     Text format    


    April 2017
  8. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    PubMed     Text format     Abstract available


  9. JENA AB, Mann NC, Wedlund LN, Olenski A, et al
    Delays in Emergency Care and Mortality during Major U.S. Marathons.
    N Engl J Med. 2017;376:1441-1450.
    PubMed     Text format     Abstract available


  10. PACKER M, O'Connor C, McMurray JJ, Wittes J, et al
    Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
    N Engl J Med. 2017 Apr 12. doi: 10.1056/NEJMoa1601895.
    PubMed     Text format     Abstract available


  11. BANGALORE S, Fayyad R, Laskey R, DeMicco DA, et al
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;376:1332-1340.
    PubMed     Text format     Abstract available


  12. KERALIYA A, Blankstein R
    Regression of Coronary Atherosclerosis with Medical Therapy.
    N Engl J Med. 2017;376:1370.
    PubMed     Text format    


  13. NISSEN SE
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1390.
    PubMed     Text format    


  14. GROSSER T
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1389.
    PubMed     Text format    


    March 2017
  15. DEFILIPPIS EM, Vaidya A, Ramani S, French C, et al
    Under Pressure.
    N Engl J Med. 2017;376:e23.
    PubMed     Text format    


  16. KULLO IJ, Fan X, Ding K
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1192-3.
    PubMed     Text format    


  17. ELLISON DH
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194.
    PubMed     Text format    


  18. RAPPAPORT SM, Neophytou AM
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1193.
    PubMed     Text format    



  19. Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194-5.
    PubMed     Text format    


  20. KOBER L
    Complete Revascularization in ST-Elevation Myocardial Infarction?
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMe1702825.
    PubMed     Text format    


  21. SMITS PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, et al
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMoa1701067.
    PubMed     Text format     Abstract available


  22. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
    Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
    PubMed     Text format     Abstract available


  23. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    PubMed     Text format     Abstract available


  24. DULLAART RP
    PCSK9 Inhibition to Reduce Cardiovascular Events.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMe1703138.
    PubMed     Text format    


  25. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    PubMed     Text format     Abstract available


  26. BELLEYCOTE EP, Lamy AR, Whitlock RP
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1087-8.
    PubMed     Text format    


  27. CHRISTIANSEN EH, Makikallio T, Holm NR
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1088-9.
    PubMed     Text format    



  28. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1089.
    PubMed     Text format    


  29. LIKOSKY DS, Baker RA
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894.
    PubMed     Text format    


  30. IPP E, Genter P, Childress K
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890-1.
    PubMed     Text format    



  31. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;379:890-1.
    PubMed     Text format    


  32. COSMI F, Laini R, Nicolucci A
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890.
    PubMed     Text format    



  33. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894-895.
    PubMed     Text format    


  34. WILLIAMS TC, Stewart E
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891.
    PubMed     Text format    



  35. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891-2.
    PubMed     Text format    


    December 2016
  36. FARSHID A
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2604.
    PubMed     Text format    


  37. URBAN P, Oldroyd K, Krackhardt F
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2603-2604.
    PubMed     Text format    



  38. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602-2605.
    PubMed     Text format    


  39. BANGALORE S
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
    N Engl J Med. 2016;375:2602-3.
    PubMed     Text format    


  40. VORA AN, Rao SV, Stone GW
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602.
    PubMed     Text format    


  41. TAGGART DP, Altman DG, Gray AM, Lees B, et al
    Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.
    N Engl J Med. 2016;375:2540-9.
    PubMed     Text format     Abstract available


  42. BATES ER
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2605.
    PubMed     Text format    


  43. KHERA AV, Emdin CA, Drake I, Natarajan P, et al
    Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.
    N Engl J Med. 2016;375:2349-2358.
    PubMed     Text format     Abstract available


  44. O'DONNELL M, Mann JF, Schutte AE, Staessen JA, et al
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    PubMed     Text format    



  45. Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    PubMed     Text format    


  46. JOHNS DM
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2407.
    PubMed     Text format    


  47. GRAUDAL N
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405-6.
    PubMed     Text format    


  48. ALDERMAN MH
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405.
    PubMed     Text format    


  49. SNIDERMAN AD, Thanassoulis G
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304.
    PubMed     Text format    


  50. MORRISON AC, Fu YP, O'Donnell CJ
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303.
    PubMed     Text format    



  51. Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2306.
    PubMed     Text format    


  52. STITZIEL NO
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2306.
    PubMed     Text format    


  53. MORIERI ML, Shah H, Doria A
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304-2305.
    PubMed     Text format    


  54. HEGELE RA
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2304.
    PubMed     Text format    


  55. CONTOU D, de Prost N
    Skin Mottling.
    N Engl J Med. 2016;375:2187.
    PubMed     Text format    


    November 2016
  56. CORREIA LC, Latado A, Porzsolt F
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1798.
    PubMed     Text format    


  57. COHEN S, Beckey C
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797.
    PubMed     Text format    



  58. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-1799.
    PubMed     Text format    


  59. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-8.
    PubMed     Text format    


    October 2016
  60. BRAUNWALD E
    Treatment of Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format    


  61. STONE GW, Sabik JF, Serruys PW, Simonton CA, et al
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  62. MYLES PS, Smith JA, Forbes A, Silbert B, et al
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  63. LAMY A, Devereaux PJ, Prabhakaran D, Taggart DP, et al
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  64. MOSLEHI JJ
    Cardiovascular Toxic Effects of Targeted Cancer Therapies.
    N Engl J Med. 2016;375:1457-1467.
    PubMed     Text format    


  65. BUCHOLZ EM, Butala NM, Ma S, Normand ST, et al
    Life Expectancy after Myocardial Infarction, According to Hospital Performance.
    N Engl J Med. 2016;375:1332-1342.
    PubMed     Text format     Abstract available


    September 2016
  66. DWYER T, Sinaiko AR, Raitakari OT
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    PubMed     Text format    


  67. SHARMA A, Lavie C
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    PubMed     Text format    



  68. Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    PubMed     Text format    


  69. MARSO SP, Bain SC, Consoli A, Eliaschewitz FG, et al
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  70. RAZA S, Blackstone EH, Sabik JF 3rd
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    PubMed     Text format    


  71. BARBATO E, Toth GG, De Bruyne B
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    PubMed     Text format    



  72. Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    PubMed     Text format    


  73. GIANNONI A, Emdin M, Passino C
    Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.
    N Engl J Med. 2016;375:1004-6.
    PubMed     Text format    


    August 2016
  74. BATES ER
    Balancing the Evidence Base on Coronary Stents.
    N Engl J Med. 2016.
    PubMed     Text format    


  75. BONAA KH, Mannsverk J, Wiseth R, Aaberge L, et al
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  76. MOKHLESI B, Ayas NT
    Cardiovascular Events in Obstructive Sleep Apnea - Can CPAP Therapy SAVE Lives?
    N Engl J Med. 2016.
    PubMed     Text format    


  77. MCEVOY RD, Antic NA, Heeley E, Luo Y, et al
    CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  78. HU K, Xu W, Williams Z
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703-4.
    PubMed     Text format    


  79. DOEHNER W, Anker SD
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703.
    PubMed     Text format    


  80. BURSZTYN M
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:702-3.
    PubMed     Text format    


  81. VISCOLI CM, Kernan WN, Young LH
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:704.
    PubMed     Text format    


  82. BROTT TG, Voeks JH, Howard VJ
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:604-5.
    PubMed     Text format    


  83. HUSSAIN MA, Al-Omran M
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603.
    PubMed     Text format    


  84. PARASKEVAS KI
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:602.
    PubMed     Text format    


  85. SAMANTA A, Afzal MR
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:601-2.
    PubMed     Text format    


  86. MATSUMURA J, Monteleone P, Rosenfield K
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603-4.
    PubMed     Text format    


  87. CHEN GC, Qin LQ
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    PubMed     Text format    


  88. KOPEL E
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    PubMed     Text format    


  89. LEOW MK
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:487-8.
    PubMed     Text format    


  90. DU H, Li L, Chen Z
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:489.
    PubMed     Text format    



  91. Sharing Data from Cardiovascular Clinical Trials--A Proposal.
    N Engl J Med. 2016;375:407-9.
    PubMed     Text format    


    July 2016

  92. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
    N Engl J Med. 2016;375:398.
    PubMed     Text format     Abstract available


  93. BASSAN M
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292-3.
    PubMed     Text format    


  94. WANITSCHEK MM, Dorler J, Alber HF
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292.
    PubMed     Text format    


  95. OHMAN EM
    Chronic Stable Angina.
    N Engl J Med. 2016;375:293.
    PubMed     Text format    


  96. LI WW, Wollersheim LW, Morshuis WJ
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91.
    PubMed     Text format    


  97. ALKHODAIR A, Cairns J
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:90-1.
    PubMed     Text format    


  98. MYLES PS, Smith JA, Painter T
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91-2.
    PubMed     Text format    


    June 2016
  99. MARSO SP, Daniels GH, Brown-Frandsen K, Kristensen P, et al
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  100. RADEMAKERS LM, Van Nunen LX
    IMAGES IN CLINICAL MEDICINE. Ventricular Septal Defect after Acute Myocardial Infarction.
    N Engl J Med. 2016;374:e28.
    PubMed     Text format    


  101. COGSWELL ME, Mugavero K, Bowman BA, Frieden TR, et al
    Dietary Sodium and Cardiovascular Disease Risk - Measurement Matters.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  102. ALEXANDER JH, Smith PK
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;374:1954-64.
    PubMed     Text format    


  103. NIOI P, Sigurdsson A, Thorleifsson G, Helgason H, et al
    Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  104. TYBJAERG-HANSEN A
    The Sialylation Pathway and Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available



  105. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    N Engl J Med. 2016;374:1898.
    PubMed     Text format    


  106. SAPP JL, Wells GA, Parkash R, Stevenson WG, et al
    Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    April 2016
  107. MICHLER RE, Smith PK, Parides MK, Ailawadi G, et al
    Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: